Closed
SectorHealthcare
3.05 4.1
24h
Min
2.89
Max
3.12
Income | 27M -59M |
---|---|
Sales | 1.4M 7.6M |
EPS | -0.08 |
Profit margin | -783.62 |
Employees | 680 |
EBITDA | 946K -40M |
Recommendations | Buy |
---|---|
12 Months Forecast | +99.34% upside |
Next Earnings | 7 maj 2025 |
---|
Market Cap | 273M 2.7B |
---|---|
Previous open | -1.05 |
Previous close | 3.05 |
By Acuity
21%
79%
47 / 386 Ranking in Healthcare
By Trading Central
Confidence
Very Strong Bullish Evidence
Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.
Price change
By TipRanks
12 Months Forecast
Average 6.08 USD 99.34%
High 8 USD
Low 4.25 USD
Based on 3 Wall Street analysts offering 12 month price targets forImmunityBio Inc - Dist in the last 3 months.
By Acuity
News Sentiment
Very Strong Bullish Evidence
Volatility
Below average
News Volume (RCV)
Average
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$